阿洛普林醇破坏纯素代谢,以增加实验性结肠炎的损害
Corey S Worledge1, Rachael E Kostelecky1, Liheng Zhou1
1Mucosal Inflammation Program, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Cells
|March 13, 2024
概括
在炎症性肠病 (IBD) 模型中,阿洛普醇会扰乱结肠中的纯素救援,损害能量平衡和伤口愈合. 这种药物通过影响结肠炎期间的上皮代谢和增殖,对肠道健康产生负面影响.
科学领域:
- 胃肠病学 胃肠病学
- 代谢医学是一种代谢医学.
- 分子生物学分子生物学
背景情况:
- 炎症性肠病 (IBD) 的特点是长期缺乏能量,阻碍肠道组织的修复.
- 微生物群失生症通过减少诸如素之类的基本上皮质代谢物,为这种能量赤字做出贡献.
- 来自微生物群的纯氨酸对结肠上皮质能量和核酸合成至关重要,支持平衡和伤口愈合.
研究的目的:
- 研究阿洛普林醇及其代谢物对结肠上皮质代谢和功能在健康和结肠炎期间的影响.
- 在IBD的背景下剖析allopurinol, purin救援途径和肠道健康之间的关系.
- 在实验性结肠炎中评估阿洛普醇对细胞代谢,增殖和组织损伤的影响.
主要方法:
- 进行了一系列体外和体内实验.
- 使用实验性结肠炎的小鼠模型.
- 分析了腺酸和肌酸代谢,AMPK信号传递和上皮细胞增殖的变化.
主要成果:
- 治疗上相关的阿洛普林醇剂量在体内调节失调的腺酸和肌酸代谢.
- 阿洛普林醇导致AMPK失调,表皮细胞增殖受损,伤口愈合减弱.
- 增加的组织损伤被观察到小鼠实验性结肠炎治疗allopurinol.
结论:
- 在IBD中,纯氨酸的挽救对于维持细胞代谢和肠道健康至关重要.
- 阿洛普林醇干扰了必不可少的纯素救援通路,对肠道上皮功能产生了负面影响.
- 研究结果表明,由于它对肠道愈合和新陈代谢的有害影响,在IBD患者中使用allopurinol应该谨慎.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
139
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
139
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
181
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
181
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
163
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
163
01:30Peptic Ulcer Disease I: Introduction
168
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
168
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
484
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
484
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
429
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
429